RIGEL PHARMACEUTICALS INC Balance Sheet
RIGL / Health Care|11 years of annual SEC 10-K data (FY2015-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 11 fiscal years. All figures from audited SEC 10-K filings.
RIGEL PHARMACEUTICALS INC had $514M in total assets and $391M in shareholders' equity as of FY2025. Total debt was $53M against $41M in cash, resulting in $12M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $40.6M | $56.7M | $32.8M | $24.5M | $18.9M | $30.4M | $22.5M | $17.6M | $38.3M | $17.6M | $43.5M |
| Accounts Receivable | $51.8M | $41.6M | $30.6M | $40.3M | $15.5M | $16.0M | $10.1M | $4.1M | $0 | $0 | $203.0K |
| Inventory | $11.5M | $6.0M | $5.5M | $9.1M | $6.6M | $1.6M | $1.4M | $894.0K | - | - | - |
| Current Assets | $240.2M | $135.1M | $99.3M | $115.9M | $154.5M | $89.0M | $119.0M | $137.0M | $117.4M | $76.2M | $129.0M |
| PP&E (Net) | $30.0K | $92.0K | $165.0K | $857.0K | $2.2M | $2.7M | $2.2M | $1.4M | $875.0K | $1.2M | $1.6M |
| Total Assets | $513.6M | $164.0M | $117.2M | $134.3M | $167.3M | $110.4M | $147.6M | $139.1M | $119.1M | $78.1M | $131.7M |
| Current Liabilities | $99.2M | $63.3M | $53.3M | $65.2M | $63.6M | $40.8M | $58.2M | $27.7M | $18.3M | $22.6M | $33.8M |
| Total Debt | $52.5M | $60.0M | $60.0M | $40.0M | $20.0M | $20.0M | $10.0M | - | - | - | - |
| Shareholders' Equity | $391.5M | $3.3M | -$28.6M | -$13.6M | $30.4M | $34.0M | $53.8M | $55.0M | $100.6M | $55.0M | $91.4M |